Health & Biotech
Zelda Therapeutics (ASX: ZLD) has changed its name to Zelira Therapeutics - ZLD (ASX: ZLD).
Below are the previous articles from Zelda Therapeutics (ASX: ZLD):
RELATED STOCKHEAD STORIES
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
Zelda’s looking for experts to help with its cannabis trials on kids and insomniacs
Health & Biotech
If pot is so hot, why aren’t cannabis directors buying their own companies?
News
Lunchtime ASX small cap wrap: who’s nursing a new years hangover
Health & Biotech
Suda signs deal with $936bn pharma company to sell its insomnia spray
Health & Biotech
Zelda and viagra mouth spray maker Suda team up to do pot
Health & Biotech
Weed week: Asia is cottoning on to cannabis. And does pot = thalidomide?
Health & Biotech
Zelda tries out weed to reduce opioid dependence
Escrow Watch
Escrow Watch: 678m shares about to flock onto the ASX
Health & Biotech
Weed week: here’s all the news driving the cannabis market (including hemp gin)
Health & Biotech
Heaps of Zelda shares are coming out of escrow – but the founders are keeping them
Health & Biotech
Weed week: here’s all the news driving ASX cannabis stocks
Health & Biotech
Weed week: it’s reefer madness as global pot stocks pass $6b in fund raising
Health & Biotech
It’s breast cancer awareness month – here are 10 ASX biotechs tackling the disease
Health & Biotech
These seven ASX-listed pot stocks are hoping for a US high
Health & Biotech
Zelda is testing cannabis to treat insomnia. (That needs to be tested?)
News